Patent References 3917825 Sustained release formulations of water soluble peptides Patent #: 5538739 InventorsAssigneeApplicationNo. 981285 filed on 12/19/1997US Classes:514/15, 9 to 11 peptide repeating units in known peptide chain424/422, Implant or insert424/423, Surgical implant or material424/425, Diffusion barrier is matrix424/426, Errodable, resorbable, or dissolving514/3, Insulin or derivative514/8, Glycoprotein (carbohydrate containing)514/12, 25 or more peptide repeating units in known peptide chain structure514/13, 16 to 24 peptide repeating units in known peptide chain514/1412 to 15 peptide repeating units in known peptide chainExaminersPrimary: Moezie, F. T.Attorney, Agent or FirmForeign Patent References
International ClassesA61D 019/00A61D 007/00 Foreign Application Priority Data1995-06-20 AUAbstractA pharmaceutical or veterinary formulation comprising deslorelin and an excipient is provided which releases in vitro deslorelin into phosphate buffered saline at 370° C. at a rate of about 2-80 μg/day for at least 200 days. The formulation may be used for prevention of reproductive function, particularly in dogs and cats, and for the treatment particularly in humans, of prostate and breast cancer and other diseases and conditions where suppression of testosterone or estradiol levels is beneficial.Other References
Field of SearchGlycoprotein (carbohydrate containing)25 or more peptide repeating units in known peptide chain structure 12 to 15 peptide repeating units in known peptide chain 16 to 24 peptide repeating units in known peptide chain 9 to 11 peptide repeating units in known peptide chain Insulin or derivative Produced by or extracted from animal tissue Implant or insert Surgical implant or material Diffusion barrier is matrix Errodable, resorbable, or dissolving | |